| 2005: Long-Term Outcome in Patients With Early Stage Tubular, Medullary and Colloid Breast Carcinoma Treated With Breast Conservation Therapy PR Anderson, G Freedman, T Li, E Ross International Journal of Radiation Oncology, Biology, Physics 66 (3), S212-S213, 2006 | 642 | 2006 |
| Objective measures of renal mass anatomic complexity predict rates of major complications following partial nephrectomy J Simhan, MC Smaldone, KJ Tsai, DJ Canter, T Li, A Kutikov, R Viterbo, ... European urology 60 (4), 724-730, 2011 | 311 | 2011 |
| Intrinsic mechanism of estradiol-induced apoptosis in breast cancer cells resistant to estrogen deprivation JS Lewis, K Meeke, C Osipo, EA Ross, N Kidawi, T Li, E Bell, NS Chandel, ... Journal of the National Cancer Institute 97 (23), 1746-1759, 2005 | 284 | 2005 |
| Locoregional recurrence of triple‐negative breast cancer after breast‐conserving surgery and radiation GM Freedman, PR Anderson, T Li, N Nicolaou Cancer: Interdisciplinary International Journal of the American Cancer …, 2009 | 201 | 2009 |
| Breast intensity-modulated radiation therapy reduces time spent with acute dermatitis for women of all breast sizes during radiation GM Freedman, T Li, N Nicolaou, Y Chen, CCM Ma, PR Anderson International Journal of Radiation Oncology* Biology* Physics 74 (3), 689-694, 2009 | 142 | 2009 |
| Tumor size predicts synchronous metastatic renal cell carcinoma: implications for surveillance of small renal masses DA Kunkle, PL Crispen, T Li, RG Uzzo The Journal of urology 177 (5), 1692-1697, 2007 | 140 | 2007 |
| Sensitive detection of minimal residual disease in patients treated for early-stage breast cancer HA Parsons, J Rhoades, SC Reed, G Gydush, P Ram, P Exman, K Xiong, ... Clinical Cancer Research 26 (11), 2556-2564, 2020 | 131 | 2020 |
| Partial nephrectomy for renal masses≥ 7 cm: technical, oncological and functional outcomes CJ Long, DJ Canter, A Kutikov, T Li, J Simhan, M Smaldone, E Teper, ... BJU international 109 (10), 1450-1456, 2012 | 128 | 2012 |
| Prognostic and biologic significance of ERBB2-low expression in early-stage breast cancer P Tarantino, Q Jin, N Tayob, RM Jeselsohn, SJ Schnitt, J Vincuilla, ... JAMA oncology 8 (8), 1177-1183, 2022 | 116 | 2022 |
| Postmastectomy chest wall radiation to a temporary tissue expander or permanent breast implant—is there a difference in complication rates? PR Anderson, G Freedman, N Nicolaou, N Sharma, T Li, N Topham, ... International Journal of Radiation Oncology* Biology* Physics 74 (1), 81-85, 2009 | 110 | 2009 |
| Does axillary boost increase lymphedema compared with supraclavicular radiation alone after breast conservation? SB Hayes, GM Freedman, T Li, PR Anderson, E Ross International Journal of Radiation Oncology* Biology* Physics 72 (5), 1449-1455, 2008 | 109 | 2008 |
| Effect of eribulin with or without pembrolizumab on progression-free survival for patients with hormone receptor–positive, ERBB2-negative metastatic breast cancer: A randomized … SM Tolaney, R Barroso-Sousa, T Keenan, T Li, L Trippa, I Vaz-Luis, ... JAMA oncology 6 (10), 1598-1605, 2020 | 103 | 2020 |
| The effect of multiple reexcisions on the risk of local recurrence after breast conserving surgery MJ O’sullivan, T Li, G Freedman, M Morrow Annals of Surgical Oncology 14, 3133-3140, 2007 | 102 | 2007 |
| Extranodal extension of metastatic papillary thyroid carcinoma: correlation with biochemical endpoints, nodal persistence, and systemic disease progression M Lango, D Flieder, R Arrangoiz, C Veloski, JQ Yu, T Li, B Burtness, ... Thyroid 23 (9), 1099-1105, 2013 | 101 | 2013 |
| Perioperative outcomes of robotic and open partial nephrectomy for moderately and highly complex renal lesions J Simhan, MC Smaldone, KJ Tsai, T Li, JM Reyes, D Canter, A Kutikov, ... The Journal of urology 187 (6), 2000-2004, 2012 | 100 | 2012 |
| Inflammatory breast cancer management in the national comprehensive cancer network: the disease, recurrence pattern, and outcome JM Matro, T Li, M Cristofanilli, ME Hughes, RA Ottesen, JC Weeks, ... Clinical breast cancer 15 (1), 1-7, 2015 | 97 | 2015 |
| A prospective study of quality of life among women undergoing risk-reducing salpingo-oophorectomy versus gynecologic screening for ovarian cancer CY Fang, C Cherry, K Devarajan, T Li, J Malick, MB Daly Gynecologic oncology 112 (3), 594-600, 2009 | 94 | 2009 |
| HER2 heterogeneity as a predictor of response to neoadjuvant T-DM1 plus pertuzumab: Results from a prospective clinical trial. O Metzger Filho, G Viale, L Trippa, T Li, DA Yardley, IA Mayer, ... Journal of Clinical Oncology 37 (15_suppl), 502-502, 2019 | 87 | 2019 |
| Presence of lobular carcinoma in situ does not increase local recurrence in patients treated with breast-conserving therapy RM Ciocca, T Li, GM Freedman, M Morrow Annals of surgical oncology 15, 2263-2271, 2008 | 85 | 2008 |
| Growth kinetics and short-term outcomes of cT1b and cT2 renal masses under active surveillance R Mehrazin, MC Smaldone, A Kutikov, T Li, JJ Tomaszewski, DJ Canter, ... The Journal of urology 192 (3), 659-664, 2014 | 80 | 2014 |
